SeekingAlpha · Aug 6, 2026
Hercules Capital: 0.1% Non-Accruals, 125% Coverage, Top BDC Value
Hercules Capital is poised for substantial gains, according to my analysis. Read more about the upsides and risks of this opportunity.
NASDAQ · HTGC
Financial Services · Asset Management
$16.70
Down-$0.23 (-1.36%)
Updated Aug 15, 2026, 5:19 AM
SID Score
5.8/10
Composite research score
Smart Money
54/100
Neutral
Price performance
1M range · 21 trading sessions · Daily adjusted prices
HTGC closed at $16.70 after 21 trading sessions, up 3.28% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $16.90 | $16.95 | $16.66 | $16.70 | 1.39M |
| Aug 13, 2026 | $16.73 | $16.98 | $16.69 | $16.93 | 1.93M |
| Aug 12, 2026 | $16.66 | $16.71 | $16.53 | $16.60 | 1.62M |
| Aug 11, 2026 | $16.66 | $16.84 | $16.55 | $16.67 | 1.84M |
| Aug 10, 2026 | $17.26 | $17.3297 | $17.025 | $17.17 | 2.22M |
| Aug 7, 2026 | $17.00 | $17.35 | $17.00 | $17.25 | 1.7M |
| Aug 6, 2026 | $16.79 | $17.18 | $16.79 | $17.05 | 1.68M |
| Aug 5, 2026 | $16.90 | $16.92 | $16.58 | $16.69 | 1.75M |
| Aug 4, 2026 | $16.83 | $16.99 | $16.75 | $16.88 | 1.52M |
| Aug 3, 2026 | $16.60 | $16.91 | $16.52 | $16.81 | 1.97M |
| Jul 31, 2026 | $16.40 | $16.59 | $16.22 | $16.42 | 2.31M |
| Jul 30, 2026 | $16.07 | $16.07 | $15.67 | $15.94 | 2.05M |
| Jul 29, 2026 | $16.19 | $16.28 | $15.93 | $15.97 | 1.5M |
| Jul 28, 2026 | $15.87 | $16.25 | $15.86 | $16.24 | 1.36M |
| Jul 27, 2026 | $15.80 | $15.93 | $15.785 | $15.79 | 1.28M |
| Jul 24, 2026 | $15.68 | $15.78 | $15.62 | $15.73 | 1.02M |
| Jul 23, 2026 | $15.80 | $15.9143 | $15.60 | $15.64 | 1.05M |
| Jul 22, 2026 | $16.19 | $16.215 | $15.91 | $15.93 | 1.48M |
| Jul 21, 2026 | $16.07 | $16.385 | $16.05 | $16.13 | 1.84M |
| Jul 20, 2026 | $16.25 | $16.26 | $15.86 | $16.06 | 1.32M |
| Jul 17, 2026 | $16.37 | $16.45 | $16.08 | $16.17 | 1.24M |
The latest Smart Investors Daily articles mentioning HTGC.
HTGC research
Company profile and research snapshot.
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 31, 2026 | Ladenburg Thalmann | Buy | — |
| May 18, 2026 | UBS | Neutral | — |
| May 6, 2026 | Piper Sandler | Neutral | — |
| Apr 22, 2026 | Citizens | Market Outperform | — |
| Apr 16, 2026 | Keefe, Bruyette & Woods | Outperform | — |
No generated briefing is available yet.
SeekingAlpha · Aug 6, 2026
Hercules Capital is poised for substantial gains, according to my analysis. Read more about the upsides and risks of this opportunity.
SeekingAlpha · Aug 4, 2026
Hercules Capital's NAV rose to $12.15 per share during Q2 on the back of healthy net investment income and realized gains. Click for more on HTGC stock.
SeekingAlpha · Aug 3, 2026
SeekingAlpha · Aug 3, 2026
Hercules Capital benefits from record venture capital activity and a fast-growing Adviser business. Read why HTGC stock is a Buy.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning HTGC.